Dr. Luke Bee Venom Wart and Corn Remover

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by a rough, “cauliflower-like” surface. Additionally, it is indicated for the removal of plantar warts, which occur on the bottom of the foot.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The wart should be soaked in warm water for approximately 15 minutes and dried thoroughly before treatment. A precision brush should be used to apply a thin layer of the medication to cover the wart completely. It is important to wait until this initial layer dries to a film before applying an additional extra thin layer if necessary.

The medication should be applied twice daily. In cases of larger or thicker warts, more frequent applications may be warranted based on clinical judgment. After three consecutive days of application, the dried film should be gently removed using tweezers, and treatment should continue as directed.

Additionally, after several days of treatment, any loosened dead skin may be removed following another soaking session. It is crucial to avoid cutting the wart during this process to prevent complications.

Contraindications

Use of this product is contraindicated in the following situations:

Application is not recommended on irritated, infected, or reddened skin due to the potential for exacerbating these conditions. The product should not be applied to moles, birthmarks, or warts with hair, nor should it be used on the face. Additionally, it is contraindicated for use on genital warts, mucous membranes, and the nose or lips.

Patients with diabetes or poor blood circulation should avoid this product, as these conditions may increase the risk of adverse effects. The product must not be used on broken skin, and individuals with a known allergy to bee stings or bee venom should refrain from use, as the product contains bee venom as an inactive ingredient. Concurrent use with any other wart removal product is also contraindicated. Finally, application to sensitive areas such as the face, armpits, or private areas is not advised.

Warnings and Precautions

For external use only. This product is contraindicated in several specific situations to ensure patient safety and efficacy.

Contraindications The product should not be applied to irritated, infected, or reddened skin. It is also contraindicated for use on moles, birthmarks, warts with hair, or on the face. Application is not recommended for genital warts, mucous membranes, or on the nose or lips. Individuals with diabetes or poor blood circulation should avoid using this product, as well as those with broken skin. Additionally, patients with a known allergy to bee stings or bee venom should refrain from use, given that bee venom is included as an inactive ingredient. The product should not be used in conjunction with any other wart removal products, nor should it be applied to sensitive areas such as the face, armpits, or private areas.

Monitoring and Discontinuation Patients are advised to discontinue use and consult a healthcare professional if discomfort, burning, or irritation persists. If excessive skin irritation occurs, or if the wart does not show improvement after 12 weeks of use, medical advice should be sought. In the event of accidental ingestion, immediate medical assistance should be obtained.

Emergency Situations In cases of swallowing the product, it is imperative to seek emergency medical help or contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated for application on irritated, infected, or reddened skin, as well as on moles, birthmarks, warts with hair, or on the face. Additionally, it should not be used on genital warts, mucous membranes, or on the nose or lips. Patients with diabetes or poor blood circulation should avoid using this product, as should those with a known allergy to bee stings or bee venom, given that the product contains bee venom as an inactive ingredient. It is also advised not to use this product in conjunction with any other wart removal products or on sensitive areas such as the face, armpits, or private areas.

During the use of this product, patients may experience transient stinging or mild irritation. It is important to avoid contact with the eyes; in the event of contact, the eyes should be flushed with water for 15 minutes. Patients should also avoid inhaling vapors and should use the product in a well-ventilated area. Users are advised not to touch the liquid film until it has completely dried.

Patients should discontinue use and consult a healthcare professional if discomfort, burning, or irritation persists, if excessive skin irritation occurs, if the wart does not improve after 12 weeks of use, or in the case of accidental ingestion. It is crucial to keep this product out of reach of children, and if swallowed, medical help or contact with a Poison Control Center should be sought immediately. This product is not recommended for use in children under 12 years of age.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. Luke Bee Venom Wart and Corn Remover (salicylic acid topical solution). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the product is swallowed, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Accidental ingestion of the product may occur, necessitating prompt intervention. It is essential for healthcare providers to be aware of the potential risks associated with overdosage and to act swiftly to mitigate any adverse effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that this product is not intended for use in children under 12 years of age.

Patients should be cautioned to avoid contact with the eyes. In the event of accidental eye contact, they should flush the eyes with water for at least 15 minutes. Additionally, patients should be instructed to avoid inhaling vapors and to use the product in a well-ventilated area to minimize any potential respiratory irritation.

Transient stinging or mild irritation may occur with use, and patients should be made aware of this possibility. They should also be advised not to touch the liquid film until it has completely dried to ensure proper application and effectiveness.

Patients who are pregnant or breastfeeding should be encouraged to consult with their healthcare provider before using the product. Furthermore, it is essential for patients to ask their doctor before use if they are currently using any other topical medications on the affected area to avoid potential interactions.

Storage and Handling

The product is supplied in a tightly sealed bottle to prevent evaporation. It is essential to store the product at a temperature range of 20–25°C (68–77°F), ensuring that it is kept away from heat and direct sunlight. The bottle should remain tightly closed when not in use.

Users are advised to inspect the safety seal before use; the product should not be utilized if the safety seal is broken or missing. Under normal conditions, the product typically forms a protective film within 20–30 seconds. However, in humid or rainy weather, the drying time may be extended.

Additional Clinical Information

The medication is administered topically and is recommended for use twice daily. In cases of larger or thicker warts, clinicians may consider more frequent applications as necessary. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Dr. Luke Bee Venom Wart and Corn Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)